ORIGINAL RESEARCH article
Front. Oncol., 15 October 2021
Sec. Breast Cancer
Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.743840
RETRACTED: Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway
- PL
Peng Li 1†
- ZL
Zhiping Lin 2,3†
- QL
Qianzheng Liu 2
- SC
Siyuan Chen 2
- XG
Xiang Gao 1
- WG
Weixiong Guo 2
- FG
Fan Gong 2
- JW
Jinsong Wei 2*
- HL
Hao Lin 2*
1. Stem Cell Research and Cellular Therapy Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
2. Orthopedic Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
3. Orthopedic Center, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
Summary
Citation
Li P, Lin Z, Liu Q, Chen S, Gao X, Guo W, Gong F, Wei J and Lin H (2021) RETRACTED: Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway. Front. Oncol. 11:743840. doi: 10.3389/fonc.2021.743840
Received
19 July 2021
Accepted
23 September 2021
Published
15 October 2021
Retracted
07 May 2026
Volume
11 - 2021
Edited by
Karen Elizabeth Nava-Castro, National Autonomous University of Mexico, Mexico
Reviewed by
Miranda Clements, National Institutes of Health (NIH), United States; Luis Costa, Santa Maria Hospital, Portugal
Updates
†These authors have contributed equally to this work and share first authorship
This article was submitted to Breast Cancer, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.